Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,802 | 28,677 | 15,364 | 90,541 | 105,138 |
| Marketable Securities | 33,481 | 51,732 | 69,488 | 67,039 | 103,353 |
| Receivables | 78,881 | 60,137 | 52,049 | 35,499 | 41,850 |
| Inventories | 53,160 | 42,110 | 54,573 | 48,382 | 41,905 |
| TOTAL | $209,014 | $188,774 | $205,435 | $254,423 | $314,196 |
| Non-Current Assets | |||||
| PPE Net | 14,863 | 20,166 | 22,160 | 23,734 | 22,737 |
| Other Non-Current Assets | 9,270 | 13,566 | 23,356 | 27,549 | 16,623 |
| TOTAL | $24,133 | $33,732 | $45,516 | $51,283 | $39,360 |
| Total Assets | $233,147 | $222,506 | $250,951 | $305,706 | $353,556 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,709 | 3,240 | 3,225 | 3,803 | 525 |
| Accrued Expenses | 34,956 | 31,515 | 37,884 | 38,979 | 63,559 |
| TOTAL | $91,457 | $79,685 | $82,355 | $71,058 | $102,503 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,026 | 24,263 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 150,315 | 152,531 | 155,024 | 157,078 | 14,561 |
| TOTAL | $175,341 | $176,794 | $155,024 | $157,078 | $14,561 |
| Total Liabilities | $266,798 | $256,479 | $237,379 | $228,136 | $117,064 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,330 | 150,329 | 119,259 | 102,141 | 91,397 |
| Common Shares | 1,521 | 1,503 | 1,191 | 1,020 | 913 |
| Retained earnings | -1,919,594 | -1,906,014 | -1,795,455 | -1,613,431 | -1,392,748 |
| Other shareholders' equity | 13 | 13 | -19 | -6 | 257 |
| TOTAL | $-33,651 | $-33,973 | $13,572 | $77,570 | $236,492 |
| Total Liabilities And Equity | $233,147 | $222,506 | $250,951 | $305,706 | $353,556 |